1) 4'-hydroxyphenytoin
4'-羟苯妥英
1.
OBJECTIVE To develop a simple reversed-phase high-performance liquid chromatography(HPLC) method for thesimultaneous determination of the antiepileptic drugs(AEDs) phenytoin(PHT),its prodrug fosphenytoin(FOS),and its metabolite 4′-hydroxyphenytoin(4′-HPPH) in human plasma.
目的建立同时测定人血浆中抗癫痫药物磷苯妥英(FOS)、苯妥英(PHT)及其主要代谢产物4′-羟苯妥英(4′-HPPH)浓度的高效液相色谱法。
2) 4-hydroxyme-phenytoin
4'-羟美芬妥英
3) fosphenytoin
磷苯妥英
1.
A new method for the preparation of fosphenytoin was discussed in this paper.
以抗癫痫药物苯妥英为原料,通过合成3-羟甲基-苯妥英、3-氯甲基-苯妥英、3-羟甲基-苯妥英磷酸二苄酯、3-羟甲基-苯妥英磷酸酯等4种中间产物,最终得到目标产物磷苯妥英,总收率35。
2.
OBJECTIVE To develop a simple reversed-phase high-performance liquid chromatography(HPLC) method for thesimultaneous determination of the antiepileptic drugs(AEDs) phenytoin(PHT),its prodrug fosphenytoin(FOS),and its metabolite 4′-hydroxyphenytoin(4′-HPPH) in human plasma.
目的建立同时测定人血浆中抗癫痫药物磷苯妥英(FOS)、苯妥英(PHT)及其主要代谢产物4′-羟苯妥英(4′-HPPH)浓度的高效液相色谱法。
4) phenytoin sodium
苯妥英钠
1.
Determination of phenytoin sodium and schisandrin in Compound Valpromide Capsule by HPLC;
HPLC测定复方丙戊酰胺胶囊中苯妥英钠和五味子醇甲的含量
2.
Pharmaceutical care of severe toxicosis of phenytoin sodium;
重度苯妥英钠中毒的药学监护
5) Phenytoin
[英]['fenitɔin] [美][,fɛnɪ'toɪn, fə'nɪto-]
苯妥英
1.
Damage of Ileum in Experimental Peritonitis in mice and Effect of Phenytoin Sodium Intervention;
小鼠实验性腹膜炎回肠组织损伤性变化以及苯妥英钠干预的影响
2.
Simultaneous determination of phenobarbitone,phenytoin and carbamazepine in human plasma by RP-HPLC;
RP-HPLC同时测定苯巴比妥、苯妥英和卡马西平的血药浓度(英文)
3.
Simultaneous separation and determination of zonisamide,phenytoin carbamazepine and carbamazepine 10,11-epoxide in human plasma using isocratic reversed-phase HPLC;
高效液相色谱法同时测定人血浆中唑尼沙胺、苯妥英、卡马西平及环氧卡马西平的浓度
6) sodium phenytoin
苯妥英钠
1.
Association of plasma sodium phenytoin concentration with CYP2C19 gene polymorphism;
苯妥英钠血药浓度与CYP2C19基因多态性关系的研究
2.
A method to determine sodium phenytoin in plasma by high performance capillary zone electrophoresis(CZE) has been established.
建立了以毛细管区带电泳测定血浆中苯妥英钠含量的方法。
3.
Objective: To investigate the effects of sodium phenytoin poly (lactide-co-glycolide) microspheres Poloxamer 407 gel (PHT-PLGA-MG) on periodontal wound healing in fenestration defects of rats, and provide an in vivo basis for the development of new PHT formulation for local drug delivery.
目的:探讨苯妥英钠聚乳酸-羟基乙酸微球泊洛沙姆407凝胶(sodiumphenytoin poly(lactide-co-glycolide)microspheres poloxamer 407 gel,PHT-PLGA-MG)对大鼠下颌磨牙区颊侧牙周骨开窗缺损牙周再生的影响,为开发苯妥英钠局部用药新剂型提供体内动物实验的依据。
补充资料：苯妥英
分子式：暂无
分子量：暂无
CAS号：暂无
性质：暂无
制备方法：暂无
用途：暂无
分子量：暂无
CAS号：暂无
性质：暂无
制备方法：暂无
用途：暂无
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条